Analysts Anticipate UnitedHealth Group Inc (UNH) to Announce $2.92 EPS

Equities analysts expect UnitedHealth Group Inc (NYSE:UNH) to announce $2.92 earnings per share for the current quarter, according to Zacks. Six analysts have made estimates for UnitedHealth Group’s earnings, with the highest EPS estimate coming in at $3.00 and the lowest estimate coming in at $2.83. UnitedHealth Group reported earnings per share of $2.37 in the same quarter last year, which indicates a positive year over year growth rate of 23.2%. The business is scheduled to announce its next quarterly earnings results on Tuesday, April 17th.

According to Zacks, analysts expect that UnitedHealth Group will report full-year earnings of $12.47 per share for the current financial year, with EPS estimates ranging from $12.00 to $12.60. For the next fiscal year, analysts expect that the company will report earnings of $14.02 per share, with EPS estimates ranging from $13.38 to $14.68. Zacks’ EPS calculations are a mean average based on a survey of research firms that cover UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business earned $2.11 EPS.

UNH has been the subject of a number of research reports. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, October 24th. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Credit Suisse Group initiated coverage on shares of UnitedHealth Group in a report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price objective for the company. Cantor Fitzgerald reiterated a “buy” rating and issued a $225.00 price objective on shares of UnitedHealth Group in a report on Monday, November 27th. Finally, Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $243.22.

Shares of UnitedHealth Group (NYSE:UNH) traded up $3.42 during midday trading on Monday, reaching $229.37. 3,620,000 shares of the company were exchanged, compared to its average volume of 4,390,000. The company has a market cap of $222,270.00, a price-to-earnings ratio of 24.14, a PEG ratio of 1.34 and a beta of 0.70. UnitedHealth Group has a 1-year low of $156.49 and a 1-year high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.

In other news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 53,396 shares of company stock valued at $12,262,067. Insiders own 0.89% of the company’s stock.

Several hedge funds have recently made changes to their positions in UNH. Aevitas Wealth Management Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at $102,000. Exane Derivatives raised its stake in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after purchasing an additional 460 shares during the period. Pathstone Family Office LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $129,000. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $110,000. Finally, Trustcore Financial Services LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $133,000. 85.65% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Analysts Anticipate UnitedHealth Group Inc (UNH) to Announce $2.92 EPS” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://stocknewstimes.com/2018/02/19/analysts-anticipate-unitedhealth-group-inc-unh-to-announce-2-92-eps.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply